Literature DB >> 2152831

Expression of the herpes simplex virus type 1 glycoprotein C gene requires sequences in the 5' noncoding region of the gene.

J P Weir1, P R Narayanan.   

Abstract

The role of the 5' noncoding region of the herpes simplex virus type 1 glycoprotein C (gC) gene in viral gene expression was investigated with recombinant herpesviruses that contained the bacterial beta-galactosidase gene under the control of the gC promoter-regulatory region. Each of these viruses had the same DNA sequences from the start of gC transcription upstream to -114 but had variable segments of the downstream 140-base-pair sequence that is between the start of gC transcription and translation. Analysis of beta-galactosidase expression and mRNA synthesis from these viruses demonstrated the importance of DNA sequences from the start of gC transcription downstream to +38 for optimal expression from the gC promoter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152831      PMCID: PMC249124     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Transcriptional and post-transcriptional controls establish the cascade of herpes simplex virus protein synthesis.

Authors:  S P Weinheimer; S L McKnight
Journal:  J Mol Biol       Date:  1987-06-20       Impact factor: 5.469

2.  Herpes simplex virus virion stimulatory protein mRNA leader contains sequence elements which increase both virus-induced transcription and mRNA stability.

Authors:  E D Blair; C C Blair; E K Wagner
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  A genetic approach to promoter recognition during trans induction of viral gene expression.

Authors:  D M Coen; S P Weinheimer; S L McKnight
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Transactivation of a late herpes simplex virus promoter.

Authors:  D Dennis; J R Smiley
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

6.  Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes.

Authors:  M Shapira; F L Homa; J C Glorioso; M Levine
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

7.  Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA.

Authors:  F L Homa; T M Otal; J C Glorioso; M Levine
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

8.  gamma 2-Thymidine kinase chimeras are identically transcribed but regulated a gamma 2 genes in herpes simplex virus genomes and as beta genes in cell genomes.

Authors:  S Silver; B Roizman
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

9.  Regulation of herpes simplex virus 1 genes: alpha gene sequence requirements for transient induction of indicator genes regulated by beta or late (gamma 2) promoters.

Authors:  P Mavromara-Nazos; S Silver; J Hubenthal-Voss; J L McKnight; B Roizman
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

10.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

View more
  16 in total

1.  Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors.

Authors:  J P Weir
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Mutational analysis of the ICP4 binding sites in the 5' transcribed noncoding domains of the herpes simplex virus 1 UL 49.5 gamma 2 gene.

Authors:  M G Romanelli; P Mavromara-Nazos; D Spector; B Roizman
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Lytic cycle gene regulation of Epstein-Barr virus.

Authors:  Wolfgang Amon; Ulrich K Binné; Helen Bryant; Peter J Jenkins; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Mutational analysis of two herpes simplex virus type 1 late promoters.

Authors:  K R Steffy; J P Weir
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene.

Authors:  K R Steffy; J P Weir
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally "neutral" segments of the viral genome.

Authors:  J Singh; E K Wagner
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

7.  Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cis-acting downstream activation sequence is mediated by a cellular transcription factor.

Authors:  J F Guzowski; J Singh; E K Wagner
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.

Authors:  B Gu; N DeLuca
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template.

Authors:  P K Kibler; J Duncan; B D Keith; T Hupel; J R Smiley
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.

Authors:  João T Proença; Heather M Coleman; Viv Connor; Douglas J Winton; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.